Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Egetis Therapeutics Major Shareholding Notification 2020

Nov 3, 2020

3152_iss_2020-11-03_a3bb773a-e495-4eff-a996-c7f291d1f4b2.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Egetis Therapeutics AB (publ)

Holder

Nortal Investments AB

Instrument

Instrument AK SE0003815604
Before the transaction
Shares 6,592,034
Voting rights 6,592,034
Transaction
Reason for major shareholding notification New share issue
Date 03/11/2020
Limit for number of shares 10 %
Limit for number of votes 10 %
After the transaction
Quantity
Shares 6,592,034
Directly held voting rights 6,592,034
Indirectly held voting rights 0
Percentage
Directly held shares 5.62 %
Directly held voting rights 5.62 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 5.62 % 6,592,034
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 5.62 % 6,592,034
Group
total
holdings
Voting rights
6,592,034
Percentage of voting rights 5.62
Published
03/11/2020 13:56
Contact
Name
Staffan Persson
Phone
0703210098
Email [email protected]
CLOSE
PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25